tiprankstipranks
Stemcell United Ltd. (AU:SCU)
ASX:SCU

Stemcell United Ltd. (SCU) Income Statement

0 Followers

Stemcell United Ltd. Income Statement

Last quarter (Q ), Stemcell United Ltd.'s total revenue was AU$―, a decrease of ― from the same quarter last year. In Q, Stemcell United Ltd.'s net income was AU$―. See Stemcell United Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 22Jun 21Jun 20Jun 19Jun 18
Total Revenue
-AU$ 14.35MAU$ 8.50MAU$ 730.36KAU$ 1.56MAU$ 290.68K
Cost of Revenue
-AU$ 12.07MAU$ 6.95MAU$ 664.21KAU$ 1.45MAU$ 224.77K
Gross Profit
-AU$ 2.29MAU$ 1.54MAU$ 66.15KAU$ 114.65KAU$ 65.91K
Operating Expense
-AU$ 5.24MAU$ 3.95MAU$ 1.45MAU$ 1.68MAU$ 1.98M
Operating Income
-AU$ -2.95MAU$ -2.41MAU$ -1.38MAU$ -1.57MAU$ -1.91M
Net Non Operating Interest Income Expense
-AU$ -62.64KAU$ -24.12K---
Other Income Expense
-AU$ 69.76KAU$ -105.32KAU$ -83.96KAU$ -697.23KAU$ -1.44M
Pretax Income
-AU$ -2.95MAU$ -2.54MAU$ -1.46MAU$ -2.27MAU$ -3.35M
Tax Provision
-AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-AU$ -3.69MAU$ -2.81MAU$ -1.39MAU$ -2.27MAU$ -3.35M
Basic EPS
-AU$ >-0.01AU$ >-0.01AU$ >-0.01--
Diluted EPS
-AU$ >-0.01AU$ >-0.01AU$ >-0.01--
Basic Average Shares
-AU$ 1.11BAU$ 834.58MAU$ 641.61M--
Diluted Average Shares
-AU$ 1.11BAU$ 834.58MAU$ 641.61M--
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
------
Net Income From Continuing And Discontinued Operation
-AU$ -3.69MAU$ -2.81MAU$ -1.39MAU$ -2.27MAU$ -3.35M
Normalized Income
-AU$ -3.69MAU$ -2.57MAU$ -1.30MAU$ -1.54MAU$ -1.91M
Interest Expense
-AU$ 62.64KAU$ 24.12K---
EBIT
-AU$ -2.88MAU$ -2.51MAU$ -1.38MAU$ -1.57MAU$ -1.91M
EBITDA
-AU$ -2.65MAU$ -2.09MAU$ -1.36MAU$ -1.55MAU$ -1.81M
Currency in AUD

Stemcell United Ltd. Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis